Jaguar Health (JAGX) Other financing activities (2014 - 2023)

Jaguar Health (JAGX) has 8 years of Other financing activities data on file, last reported at $6000.0 in Q4 2023.

• Other financing activities for Q4 2023 came in at $6000.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was -$14000.0 (down 100.63% YoY), and the FY2023 annual result was $1.2 million, changed N/A from the prior year.
• Other financing activities climbed to $6000.0 in Q4 2023 per JAGX's latest filing, from -$20000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $1.6 million in Q3 2019 and troughed at -$1.6 million in Q4 2019.
• A 4-year average of $248272.7 and a median of $15000.0 in 2023 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2020 and 2023: Other financing activities plunged 74.88% in 2020, then soared 792.13% in 2023.
• A 4-year view of Other financing activities shows it stood at -$1.6 million in 2019, then surged by 172.55% to $1.1 million in 2020, then plunged by 115.63% to -$178000.0 in 2022, then soared by 103.37% to $6000.0 in 2023.
• Business Quant data shows JAGX's Other financing activities at $6000.0 in Q4 2023, -$20000.0 in Q3 2023, and $15000.0 in Q2 2023.